2002 – 2008 COO President and CEO of Valeant Pharmaceuticals International

• Achieved a growth in sales of 69% and earnings increase of 135%
• Led a major re-structuring of the company
• Established a highly effective R&D capability which developed a best-in-class epilepsy compound and a promising pro-drug for hepatitis C, both in Phase III

1988 – 2002 Corporate Executive Team for GlaxoSmithKline

• President, Global Manufacturing & Supply and ran Glaxo Dermatology and Cerenex Pharmaceuticals
• Managed all Sales and Marketing for GlaxoWellcome’s US operations, launching 32 products, eight of which achieved sales of greater than $1billion

1980 – 1988 Executive Positions at Bristol Myers

• Responsible for Commercial, Technical Operations and R&D

Other Achievements

• Manufacturing Manager for Proctor and Gamble
• Graduated from the United States Military Academy at West Point in 1974 and served on active duty as an officer in the United States Army from 1974 – 1979
• Achieved a Master of Public Administration in 1976 and Master of Business Administration in 1979 from Jacksonville State University whilst on active duty
• Has also served on the board of directors for:
• Pharmaceutical Research and Manufacturing Association (PhRMA);
• BICOM;
• CEO Roundtable for the University of California at Irvine
• Dean’s Executive Forum at Cal State Fullerton;
• CEO Council on Cancer;
• Health Sector Advisory Board at Duke University;
• Leadership Forum of the International Society of Pharmaceutical Engineers and as a visiting lecturer at Cambridge University;
• Non-profit organizations in Raleigh-Durham, NC and Orange County, CA and with the United Way.